Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Leiomyoma 2Ovarian Neoplasms 1Osteoporosis 1Myocardial Ischemia 1Heart Diseases 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Cholecalciferol 4Calcium Carbonate 4Alendronate 4Letrozole 3Denosumab 3Calcium 3Absorptiometry, Photon 3Calcium Gluconate 2Toremifene 1Spectrum Analysis 1Radiotherapy 1Progestins 1Ibandronic Acid 1Hormone Replacement Therapy 1Goserelin 1Gonadotropin-Releasing Hormone 1Geritol 1Estrogens 1Estrogen Replacement Therapy 1Estrogen Antagonists 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium Citrate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Osteoporosis × Progestins × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡